logo
Plus   Neg
Share
Email

Spring Bank Stops Dosing Of Inarigivir Patients In Chronic HBV Trial

Spring Bank Pharmaceuticals Inc. (SBPH) said that it stopped the dosing of inarigivir 400mg in the Phase 2b CATALYST trials, due to clinical findings observed in the CATALYST 2 trial of virally-suppressed chronic hepatitis B virus patients.

Laboratory findings revealed that three subjects participating in this trial showed evidence of hepatocellular dysfunction and an elevation of alanine transaminase or ALT potentially consistent with liver injury rather than immune flares.

"... We are certainly disappointed to stop our current Phase 2 inarigivir trials, but ensuring patient safety and care is of paramount importance to us," said Martin Driscoll, president and chief executive officer of Spring Bank.

Phase 2b CATALYST trials were examining the use of inarigivir soproxil 400mg for the treatment of chronic hepatitis B virus (HBV). In addition, the company stopped dosing and enrollment in all other studies of inarigivir in subjects with chronic HBV.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The Federal Trade Commission (FTC) is in the process of sending out refund checks to consumers who were allegedly misled by Office Depot, Inc. and its software provider Support.com, Inc., into buying computer repair products and services. Out of $34 million, being the total amount of checks, Office Depot paid $25 million and Support.com paid $10 million as part of 2019 settlement. Gap Inc. partnered with fashion resale platform thredUP to facilitate the exchange of secondhand cloths. The retailer in a blog post said its customers can bring secondhand clothes in exchange for shopping credit that can be redeemed at Gap, Banana Republic, Athleta, or Janie and Jack. Customers who redeem their credits at Gap brands will receive an additional 15 percent payout bonus. Coca-Cola Co. (KO) on Friday reaffirmed its guidance for the full-year 2020 and provided an update on the expected impact from COVID-19 on first quarter 2020 results, ahead of its presentation at the Consumer Analyst Group of New York (CAGNY) Conference. For fiscal 2020, the company continues to project...
RELATED NEWS
Follow RTT
>